Novak Corporation made the following purchases of investments during 2020, the first year in which Novak invested in equity securities: 1. 2. 3. On January 15, purchased 7,470 shares of Nirmala Corp.'s common shares at $27.80 per share plus commission of $1,644. On April 1, purchased 4,150 shares of Oxana Corp.'s common shares at $43 per share plus commission of $2,797. On September 10, purchased 5,810 shares of WTA Corp's preferred shares at $22.00 per share plus commission of $2,415. On May 20, 2020, Novak sold 2,490 of the Nirmala common shares at a market price of $29 per share less brokerage commissions of $2,366. The year-end fair values per share were as follows: Nirmala $25, Oxana $46, and WTA $23. The chief accountant of Novak tells you that Novak Corporation holds these investments with the intention of selling them in order to earn short-term profits from appreciation in their prices and accounts for them using the FV-NI model. Assume that Novak Corporation follows IFRS 9. Prepare the journal entry for the sale of the 2,490 Nirmala shares on May 20. (Credit account titles are automatically indented when the amount is entered. Do not indent manually. If no entry is required, select "No Entry" for the account titles and enter O for the amounts.) Credit